Leveljump Healthcare (TSXV:JUMP) - Stock Price, News & Analysis

JUMP Stock Overview

Operates as a medical diagnostic imaging company.

JUMP fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Rewards

Earnings have grown 10.5% per year over the past 5 years

Risk Analysis

Does not have a meaningful market cap (CA$5M)

Shares are highly illiquid

Shareholders have been diluted in the past year

Latest financial reports are more than 6 months old

Leveljump Healthcare Corp. Competitors

Jack Nathan Medical

TSXV:JNH

CA$3.0m

Newtopia

TSXV:NEWU

CA$5.2m

NeuPath Health

TSXV:NPTH

CA$10.7m

Braxia Scientific

CNSX:BRAX

CA$1.4m

Price History & Performance

Summary of all time highs, changes and price drops for Leveljump Healthcare
Historical stock prices
Current Share Price	CA$0.05
52 Week High	CA$0.10
52 Week Low	CA$0.05
Beta	2.35
11 Month Change	0%
3 Month Change	-28.57%
1 Year Change	-16.67%
33 Year Change	-81.82%
5 Year Change	n/a
Change since IPO	-87.50%

Recent updates

Shareholder Returns

	JUMP	CA Healthcare	CA Market
7D	0%	2.4%	-0.3%
1Y	-16.7%	19.2%	10.9%

Return vs Industry: JUMP underperformed the Canadian Healthcare industry which returned 15.4% over the past year.

Return vs Market: JUMP underperformed the Canadian Market which returned 10.1% over the past year.

Price Volatility

Is JUMP's price volatile compared to industry and market?
JUMP volatility
JUMP Average Weekly Movement	n/a
Healthcare Industry Average Movement	4.6%
Market Average Movement	8.1%
10% most volatile stocks in CA Market	16.7%
10% least volatile stocks in CA Market	3.0%

Stable Share Price: JUMP's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine JUMP's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	27	Mitch Geisler	www.leveljumphealthcare.com

Leveljump Healthcare Corp., together with its subsidiaries, operates as a medical diagnostic imaging company. The company provides teleradiology services to its client hospitals. It also owns and operates imaging centers.

Leveljump Healthcare Corp. Fundamentals Summary

How do Leveljump Healthcare's earnings and revenue compare to its market cap?
JUMP fundamental statistics
Market cap	CA$4.83m
Earnings (TTM)	-CA$1.06m
Revenue (TTM)	CA$11.63m

0.4x

P/S Ratio

-4.6x

P/E Ratio

Is JUMP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
JUMP income statement (TTM)
Revenue	CA$11.63m
Cost of Revenue	CA$8.32m
Gross Profit	CA$3.31m
Other Expenses	CA$4.37m
Earnings	-CA$1.06m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.011
Gross Margin	28.49%
Net Profit Margin	-9.09%
Debt/Equity Ratio	67.4%

How did JUMP perform over the long term?

See historical performance and comparison

JUMP Stock Overview

Rewards

Risk Analysis

Leveljump Healthcare Corp. Competitors

TSXV:JNH

CA$3.0m

TSXV:NEWU

CA$5.2m

TSXV:NPTH

CA$10.7m

CNSX:BRAX

CA$1.4m

Price History & Performance

Recent News & Updates

High number of new and inexperienced directors

Third quarter 2023 earnings released: CA$0.017 loss per share (vs CA$0.002 loss in 3Q 2022)

Second quarter 2023 earnings released: CA$0.003 loss per share (vs CA$0.002 loss in 2Q 2022)

Leveljump Healthcare Corp. announced that it has received CAD 0.9 million in funding

Full year 2022 earnings released: EPS: CA$0.003 (vs CA$0.047 loss in FY 2021)

Third quarter 2022 earnings released: CA$0.002 loss per share (vs CA$0.009 loss in 3Q 2021)

Recent updates

High number of new and inexperienced directors

Third quarter 2023 earnings released: CA$0.017 loss per share (vs CA$0.002 loss in 3Q 2022)

Second quarter 2023 earnings released: CA$0.003 loss per share (vs CA$0.002 loss in 2Q 2022)

Leveljump Healthcare Corp. announced that it has received CAD 0.9 million in funding

Full year 2022 earnings released: EPS: CA$0.003 (vs CA$0.047 loss in FY 2021)

Third quarter 2022 earnings released: CA$0.002 loss per share (vs CA$0.009 loss in 3Q 2021)

High number of new and inexperienced directors

Leveljump Healthcare Corp. announced that it expects to receive CAD 10 million in funding

Second quarter 2022 earnings released: CA$0.002 loss per share (vs CA$0.012 loss in 2Q 2021)

Leveljump Healthcare Corp. announced that it has received CAD 0.87875 million in funding

First quarter 2022 earnings released: CA$0.004 loss per share (vs CA$0.017 loss in 1Q 2021)

Full year 2021 earnings released: CA$0.047 loss per share (vs CA$4.36 loss in FY 2020)

No independent directors

Leveljump Healthcare Corp. (TSXV:JUMP) entered into an agreement to acquired additional 10.44% stake in Médical Temps Réel inc. for CAD 0.99 million.

Leveljump Healthcare Corp., Annual General Meeting, Jun 21, 2022

Leveljump Healthcare Corp. (TSXV:JUMP) acquired a 10.8% stake in Shaw Lens Inc./Shaw Vision Inc. from minority shareholders for $0.104 million.

Leveljump Healthcare Corp. announced that it expects to receive CAD 2 million in funding

Leveljump Healthcare Corp. announced that it has received CAD 1.524284 million in funding

Leveljump Healthcare Corp. announced that it has received CAD 0.477785 million in funding

Leveljump Healthcare Corp. (TSXV:JUMP) completed the acquisition of Three Diagnostic Imaging Clinics Located in Ontario.

Leveljump Healthcare Corp. announced that it expects to receive CAD 2.5 million in funding

Leveljump Healthcare Corp. (TSXV:JUMP) agreed to acquire additional 7.82% in Real Time Medical Inc. for CAD 0.15 million

Leveljump Healthcare Corp. Receives Ministry of Health Grants Approval for License Transfer of IHF to Jump

Leveljump Healthcare Corp. (TSXV:JUMP) completed the acquisition of 14.6% stake in Real Time Medical.

Third quarter 2021 earnings: Revenues in line with analyst expectations

Leveljump Healthcare Corp. (TSXV:JUMP) offered to acquire 19.9% stake in Real Time Medical.

Leveljump Healthcare Corp. announced that it expects to receive CAD 1.48142 million in funding

Leveljump Healthcare Corp. (TSXV:JUMP) acquired 23.8% stake in Shaw Lens Inc. and Shaw Vision Inc. for CAD 0.13 million.

Second quarter 2021 earnings released: CA$0.012 loss per share

Leveljump Healthcare Corp. announced that it has received CAD 0.1 million in funding

Leveljump Healthcare Corp. announced that it expects to receive CAD 0.1 million in funding

Leveljump Healthcare Corp. announced that it has received CAD 1.5 million in funding

Independent Director has left the company

Leveljump Healthcare Corp. announced that it expects to receive CAD 1.5 million in funding

Full year 2020 earnings released: CA$4.36 loss per share

LevelJump Healthcare Corp. Provides Financial Guidance for 2021

Canadian Teleradiology Services, Inc. Secures Contracts with Network of Four Hospitals

Canadian Teleradiology Services, Inc. Selects RamSoft Inc. as its New PACS Technology Supplier

Leveljump Healthcare Corp. Announces Board Appointments

Shareholder Returns

Price Volatility

About the Company

Leveljump Healthcare Corp. Fundamentals Summary

0.4x

-4.6x

Earnings & Revenue